Breakthrough in Wilson Disease Screening

Breakthrough in Wilson Disease Screening
Two spot urines could revolutionize early detection of Wilson disease in young children, potentially preventing serious liver and brain damage before symptoms appear
Learn More
About Screening
What is Wilson Disease?
A Genetic Condition with severe outcomes
Wilson disease is an inherited disorder where copper builds up in the body, particularly in the liver and brain. It's caused by mutations in the ATP7B gene, which normally helps remove excess copper from the body. 
Without treatment, copper accumulation can cause serious liver disease, neurological problems, and psychiatric symptoms. However, early detection and treatment can prevent these complications entirely.
Prevalence
As high as 1 in 5,400 in Hong Kong and Southern China
Age of Onset
Symptoms typically appear during teenage years or early adulthood
Treatment Success
Early treatment with zinc therapy can prevent symptoms from developing

The Challenge of Early Detection
Wilson disease can be difficult to diagnose because symptoms vary widely and may not appear until significant damage has occurred. Traditional screening methods using blood tests during infancy have shown limited success, The latest high sensitive assay to screen Wilson disease with newborn blood spot samples may have a false-negative rates as high as 7.9%.
Birth to Age 4
No symptoms present. Copper begins accumulating in the body. (NBS bloodspot screening possible but treatment will start later)
Ages 4-11
Pre-symptomatic window. Ideal time for screening and early intervention. (ideal timing for pre-symptomatic treatment using zinc)
Teenage Years
Symptoms may begin appearing. Liver problems often develop first.
Early Adulthood
Neurological and psychiatric symptoms may emerge if untreated.
This creates a critical 10-year window between ages 4-11 when screening can identify children before symptoms develop, allowing treatment to begin when it's most effective.
The Newborn Approach (Option A)
Blood Spot Test
This method that uses blood spot test was a Multiplexed LC-MS/MS Proteomic Assay reported by Klippel et al. This assay measures the signature peptides of ATP7B. Patients with Wilson Disease have low levels of these peptides which act as markers of Wilson Disease. 
Hahn et al in Washington State used this in newborn screening, using archival dried blood spots to screen for Wilson disease. Recently, the Washing State Board of Health has supported this method by voting to include Wilson Disease (WD) in its newborn screening program, becoming the first jurisdiction globally to do so.
A New Screening Approach (Option B)
Simple Spot Urine Test
Researchers in Hong Kong developed a non-invasive screening method using spot urine samples to measure copper levels. Unlike 24-hour urine collections, spot samples are easy to collect and practical for screening large numbers of children. 
The test measures copper concentration in urine, which is elevated in children with Wilson disease due to the body's inability to properly process copper.

01
Initial Screening
Children provide two spot urine samples on different days. Samples are tested for copper concentration using ICP-mass spectrometry.
02
Call-back Testing
Children with elevated copper levels undergo blood tests to measure ceruloplasmin and copper levels.
03
Genetic Confirmation
Genetic testing of the ATP7B gene confirms the diagnosis in children with abnormal blood results.
04
Treatment Begins
Confirmed cases start zinc therapy to prevent copper accumulation and symptom development.
Remarkable Study Results
In a prospective study of 193 healthy school children aged 4-11 years in Hong Kong, researchers successfully identified two siblings with Wilson disease and one carrier4all completely asymptomatic at the time of diagnosis.
193
Children Screened
Healthy school children aged 4-11 participated in the study
86%
Participation Rate
High acceptance shows feasibility for universal screening
5%
Call-Back Rate
Only 10 children required follow-up testing, minimizing healthcare burden
2
Cases Detected
Two pre-symptomatic Wilson disease patients identified and treated
"Both children were completely asymptomatic at diagnosis. They started zinc therapy immediately and remained symptom-free at 6-month follow-up, demonstrating the power of early detection."
How the Test Works
The Science Behind It
The screening uses a simple cut-off value: urine copper concentration of 0.5 μmol/L or higher indicates the need for follow-up testing. This threshold showed excellent sensitivity in detecting Wilson disease while maintaining high specificity to avoid false positives. 
The test works because children with Wilson disease excrete significantly more copper in their urine than healthy children—typically more than twice the normal amount. This difference is large enough to reliably distinguish affected children from healthy ones.
0.21
Average Copper Level
Mean urine copper in healthy children (μmol/L)
0.5
Screening Cut-Off
Threshold for follow-up testing (μmol/L)
95%
Specificity 
Accuracy in identifying health children
Why Early Detection Matters
Prevents Organ Damage
Treatment before symptoms appear prevents irreversible liver and brain damage that would otherwise occur.
Simple Treatment
Zinc therapy is highly effective, safe, and well-tolerated when started early. It works by blocking copper absorption.
Normal Life Quality
Children treated before symptoms develop can lead completely normal, healthy lives without complications.
Family Screening
Identifying one case allows screening of siblings and family members who may also be affected.
Success Story: Both children diagnosed in this study started zinc therapy immediately and remained completely symptom-free at their 6-month follow-up, with normal liver function tests and no neurological symptoms.
Advantages Over Other Screening Methods
Why Spot Urine Screening Excels 
Unlike newborn blood spot screening, spot urine screening targets school- age children when copper accumulation becomes more detectable. 
The test is completely non-invasive, requiring only a simple urine sample rather than blood draws. It's also more practical than 24-hour urine collections, which are difficult for young children to complete accurately.
Non-Invasive
Simple urine collection, no needles or blood draws required
Practical
Spot samples easier than 24-hour collections for children
Optimal Timing
Screens during critical pre-symptomatic window (ages 4-11)
Widely Available
Uses standard ICP-MS technology found in most labs
Feasible for Universal Screening
This screening approach fulfills all modern criteria for universal health screening programs, making it suitable for implementation to school children in the communities.
Important Health Problem
Wilson disease prevalence in Hong Kong is as high as 1 in 5,400, making it one of the more common inherited metabolic diseases.
Effective Treatment Available
Zinc therapy is proven highly effective when started before symptoms appear, preventing disease progression.
Recognizable Early Stage
Pre-symptomatic Wilson disease is now well-characterized, with copper accumulation detectable before organ damage.
Suitable Test Available
Spot urine copper measurement is validated, accurate, and practical for large-scale screening.
Acceptable to Population
86% participation rate demonstrates high acceptance among families and children.
Critical Window Period
The 10-year pre-symptomatic period (ages 4-14) provides ample opportunity for screening and intervention.
The Future of Wilson Disease Screening
Next Steps
This successful pilot study paves the way for larger-scale implementation of universal Wilson disease screening in schools. Researchers are calling for multi-center validation studies across different populations and integration with existing school health programs.
Countries with high Wilson disease prevalence should consider implementing similar screening programs. The relatively simple technology requirements and acceptable cost make this approach feasible even in resource-limited settings.
Expand Research
Multi-center studies across diverse populations to refine screening protocols
Long-Term Follow-Up
Track outcomes of screen-detected cases to document treatment success
School Integration
Incorporate screening into existing school health examination programs
Global Implementation
Share protocols with countries worldwide, especially those with high prevalence
A Paradigm Shift: "This represents a fundamental change from reactive treatment of symptomatic disease to proactive prevention of organ damage through early detection and therapy before symptoms onset."
By enabling early detection and treatment of Wilson disease before symptoms appear, spot urine screening has the potential to fundamentally change the natural history of this condition, preventing irreversible complications and allowing affected children to lead completely normal, healthy lives.
References
MDPI
Advancing Newborn Screening in Washington State: A Novel Multiplexed LC-MS/MS Proteomic Assay for Wilson Disease and Inborn Errors of Immunity | MDPI
For many genetic disorders, there are no specific metabolic biomarkers nor analytical methods suitable for newborn population screening, even where highly effective preemptive treatments are available.
The New York Academy of Sciences
NYAS Publications
Wilson's disease is an autosomal recessive disorder of copper transport caused by mutations in the gene encoding an ATPase, ATP7B. Early detection of Wilson's disease is critical because effective me...
Pathology
Reference intervals of spot urine copper excretion in preschool children and potential application in pre-symptomatic screening of Wilson disease
The objectives were to determine the reference intervals of spot urine copper excretion indexes in pre-school children and to evaluate their utility in screening for Wilson disease (WD).With spot urine collected from a control sample of preschool children (aged 3–7 years, n=153), the reference intervals of spot urine copper excretion indexes and their biological variation were defined. In order to investigate their utility performance in screening for WD in this age group, multiple spot urine sa
medRxiv
PROSPECTIVE SCREENING OF WILSON DISEASE IN PRIMARY SCHOOL CHILDREN USING SPOT URINE: AN UNFORESEEN SUCCESS IN CASE DIAGNOSIS IN A PILOT STUDY
Background Wilson disease (WD) is a rare but commonly under-diagnosed inherited metabolic disease. Patients who are diagnosed early before disease onset (pre-symptomatic WD) have a good response to treatment. For universal screening in children, spot urine tests are more feasible than 24-hour urine collection. We previously established reference ranges for spot urine copper excretion indices. Here, we evaluated their screening performance in a prospective cohort of school children.  Methods Two 
SSRN
Advocacy for Wilson Disease (WD) Screening in Newborn Screening (NBS) Programs
Wilson Disease (WD) is an autosomal recessive disorder caused by ATP7B gene mutations, leading to impaired copper excretion. Clinically symptoms of WD can vary